The invention concerns agents with antibacterial activity their production and use in the treatment of bacterial infections in animals including man. The agents are derivatives of vancomycin type antibiotics of structure X W L V wherein X is hydrogen acetyl or a lipophilic membrane insertive element W is a basic peptide or basic amino acid L is a linking group and V is a glycopeptide moiety which inhibits peptidoglycan biosynthesis in bacteria.
